Brenda M Kazemier
Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study
Kazemier, Brenda M; Schneeberger, Caroline; De Miranda, Esteriek; Van Wassenaer, Aleid; Bossuyt, Patrick M; Vogelvang, Tatjana E; Reijnders, Frans J L; Delemarre, Friso M C; Verhoeven, Corine J M; Oudijk, Martijn A; Van Der Ven, Jeanine A; Kuiper, Petra N; Feiertag, Nicolette; Ott, Alewijn; De Groot, Christianne J M; Mol, Ben Willem J; Geerlings, Suzanne E
Authors
Caroline Schneeberger
Esteriek De Miranda
Aleid Van Wassenaer
Patrick M Bossuyt
Tatjana E Vogelvang
Frans J L Reijnders
Friso M C Delemarre
Professor CORINE VERHOEVEN C.Verhoeven@nottingham.ac.uk
PROFESSOR OF MIDWIFERY
Martijn A Oudijk
Jeanine A Van Der Ven
Petra N Kuiper
Nicolette Feiertag
Alewijn Ott
Christianne J M De Groot
Ben Willem J Mol
Suzanne E Geerlings
Abstract
Background
The prevalence of asymptomatic bacteriuria (ASB) in pregnancy is 2-10% and is associated with both maternal and neonatal adverse outcomes as pyelonephritis and preterm delivery. Antibiotic treatment is reported to decrease these adverse outcomes although the existing evidence is of poor quality.
Methods/Design
We plan a combined screen and treat study in women with a singleton pregnancy. We will screen women between 16 and 22 weeks of gestation for ASB using the urine dipslide technique. The dipslide is considered positive when colony concentration ≥105 colony forming units (CFU)/mL of a single microorganism or two different colonies but one ≥105 CFU/mL is found, or when Group B Streptococcus bacteriuria is found in any colony concentration. Women with a positive dipslide will be randomly allocated to receive nitrofurantoin or placebo 100 mg twice a day for 5 consecutive days (double blind). Primary outcomes of this trial are maternal pyelonephritis and/or preterm delivery before 34 weeks. Secondary outcomes are neonatal and maternal morbidity, neonatal weight, time to delivery, preterm delivery rate before 32 and 37 weeks, days of admission in neonatal intensive care unit, maternal admission days and costs.
Discussion
This trial will provide evidence for the benefit and cost-effectiveness of dipslide screening for ASB among low risk women at 16–22 weeks of pregnancy and subsequent nitrofurantoin treatment.
Trial registration
Dutch trial registry: NTR-3068
Citation
Kazemier, B. M., Schneeberger, C., De Miranda, E., Van Wassenaer, A., Bossuyt, P. M., Vogelvang, T. E., Reijnders, F. J. L., Delemarre, F. M. C., Verhoeven, C. J. M., Oudijk, M. A., Van Der Ven, J. A., Kuiper, P. N., Feiertag, N., Ott, A., De Groot, C. J. M., Mol, B. W. J., & Geerlings, S. E. (2012). Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy and Childbirth, 12, Article 52. https://doi.org/10.1186/1471-2393-12-52
Journal Article Type | Article |
---|---|
Acceptance Date | Jun 21, 2012 |
Online Publication Date | Jun 21, 2012 |
Publication Date | 2012 |
Deposit Date | Aug 31, 2023 |
Publicly Available Date | Sep 1, 2023 |
Journal | BMC Pregnancy and Childbirth |
Publisher | Springer Verlag |
Peer Reviewed | Peer Reviewed |
Volume | 12 |
Article Number | 52 |
DOI | https://doi.org/10.1186/1471-2393-12-52 |
Public URL | https://nottingham-repository.worktribe.com/output/23513731 |
Publisher URL | https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/1471-2393-12-52 |
Files
1471-2393-12-52
(250 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/2.0/
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search